Jubilant Launched Remdesivir in India for COVID-19 Treatment

JUBI-R by Jubliant Life Sciences in Indian market is available at a price of Rs 4,700 and available to over 1,000 hospitals will be used for COVID-19.

Jubilant Launched Remdesivir in India for COVID-19 Treatment

Sharing is caring!

CATEGORIES
TAGS
Share This

COMMENTS

Wordpress (0)
Disqus (0 )
shares
%d bloggers like this: